AC Immune SA (ACIU) earnings
Quarterly results of AC Immune SA as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Latest quarter: Q4 FY2018
In Q4 FY2018 (ended December 31, 2018) AC Immune SA reported revenue of CHF 1.4M (-91.5% on the same quarter a year earlier) and a net loss of CHF 14.7M.
Diluted earnings per share were -CHF 0.22.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q4 FY2018 | CHF 1.4M | -91.5% | -CHF 14.7M | -CHF 0.22 |
| Q3 FY2018 | CHF 2.3M | +114.6% | -CHF 13.5M | -CHF 0.21 |
| Q2 FY2018 | CHF 2M | +169.3% | -CHF 11.1M | -CHF 0.19 |
| Q1 FY2018 | CHF 1.5M | -27.3% | -CHF 11.6M | -CHF 0.20 |
| Q4 FY2017 | CHF 16.4M | - | CHF 4.2M | CHF 0.07 |
| Q3 FY2017 | CHF 1.1M | - | -CHF 8.8M | -CHF 0.15 |
| Q2 FY2017 | CHF 753K | - | -CHF 12.3M | -CHF 0.22 |
| Q1 FY2017 | CHF 2M | - | -CHF 9.5M | -CHF 0.17 |
What were AC Immune SA's latest quarterly results?
For Q4 FY2018, which ended December 31, 2018, AC Immune SA reported revenue of CHF 1.4M and a net loss of CHF 14.7M. The figures come from its filing with the SEC.
Is AC Immune SA's revenue growing?
Revenue in Q4 FY2018 was CHF 1.4M, down 91.5% from CHF 16.4M in the same quarter a year earlier.
Get an email when ACIU reports
Follow ACIU and we email you its next results the day they are filed, with the numbers explained.